Developer docs
API playgroundTry for free, no card

Search company profiles

Afortiori Development

Full company profile

uuid002676v

Namestring
Afortiori Development
Legal namestring
Afortiori Development Limited
Websiteurl
aftdev.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Afortiori Development Limited is a privately-held, founder-led Contract Research Organisation (CRO) headquartered in Nottingham, England, with additional registered offices in Galway, Ireland and the United States. The company provides full-service clinical trial design, planning and management for healthcare product developers, with current emphasis on medical devices (Classes I–III), drugs, diagnostics, and wearable technology products. Its offering is organised around three integrated phases — Clinical Strategy Planning (a half-day validation workshop), Clinical Trial Design, and Clinical Trial Management — supported by specialised modules for Medical Writing, Data Monitoring Committee services, Patient and Public Involvement, and Clinical Evaluation Report (CER) preparation. Delivery is professional services-based, project-priced and not publicly disclosed, with engagements sourced through direct enterprise sales, referrals, and a partner channel for CROs without UK/Ireland representation.

Operationally, Afortiori is built on a specialist team of medical writers, data managers, biostatisticians, regulatory specialists, medical monitors, clinical project managers, clinical research associates, and reimbursement specialists, anchored by co-founders Dr Nicola Wall and Elizabeth Ralph. The firm differentiates on a risk-based clinical trial management approach, ISO 9001:2015 certification, and a global trusted-partner network of clinicians, biostatisticians, regulatory and reimbursement experts. Customer evidence to date is limited and project-based, including a Japanese Class I medical device company entering the European market, a leading Irish university (multi-site Phase 2 SARS-CoV-2 study), and a small cardiovascular biotech (Phase I trials). The company is independently owned by its two founders with no disclosed external investment, parent company, or restructuring events.

Short descriptiontext

Afortiori Development is a founder-led UK-based full-service CRO providing clinical trial strategy, design, and management services for biopharmaceutical, medical device, diagnostics, and wearable technology innovators across the UK, Ireland, and the US.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersGalway, Ireland
HQ citystring
Galway
HQ countrystring
Ireland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial services, contract research organization, medical device clinical trials, clinical strategy planning, clinical trial management
Industry4 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAOAB
Data Management, Biostatistics & Statistical Programming FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAC
Medical Writing & Clinical Documentation FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Other Scientific and Technical Consulting Services541690
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Services (CRO)
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Clinical Trial CRO Services
TypeProfessional Services
Description

Full-service clinical research organisation providing end-to-end clinical trial services including strategy planning, trial design, and trial management. Revenue generated through professional services contracts for medical devices, drugs, and diagnostics development.

aftdev.com
2Clinical Strategy Planning Workshops
TypeProfessional Services
Description

Half-day focused strategy workshops offering affordable, efficient approach to help clients develop clinical trial strategies. Workshop provides understanding of optimum clinical trial strategy, regulatory strategy insights, funding requirements, and access to global network of expertise.

aftdev.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Afortiori Development is a full-service Contract Research Organization (CRO) that designs, plans, and manages clinical trials and post-market clinical follow-up studies for medical devices, drugs, and diagnostics. The company offers a three-phase integrated service — Clinical Strategy Planning Workshops, Clinical Trial Design Services, and Clinical Trial Management Services — supplemented by Medical Writing, Data Monitoring Committee (DMC), Patient and Public Involvement (PPI), and Clinical Evaluation Report (CER) services. Its core offering is delivered as bespoke professional services engagements tailored to healthcare innovators across the UK, Ireland, the United States, and globally.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Cost-effective clinical trial design with best chance of success
+1 more record
Product overview1 text field

Afortiori Development is a full-service Contract Research Organization (CRO) offering a comprehensive suite of clinical trial services. The core offering consists of three integrated phases: Clinical Strategy Planning Workshop (initial strategy and planning), Clinical Trial Design Services (protocol development and trial architecture), and Clinical Trial Management Services (execution and oversight). These are supplemented by specialized service modules including Medical Writing, DMC Services, PPI Services, and Clinical Evaluation Report (CER) Services. The integrated approach spans from initial concept through post-market clinical follow-up studies essential for regulatory approval and market uptake of healthcare products.

Product and service7 records
1Clinical Strategy Planning Workshop
CategoryClinical Strategy Planning
Description

A focused half-day strategy workshop led by founders Dr Nicola Wall and Elizabeth Ralph with clinical trial specialists, clinicians, biostatisticians, and regulatory/reimbursement experts. Delivers an understanding of the optimum clinical trial strategy, regulatory and commercial considerations, funding requirements, and access to a global network of expertise. Designed as an affordable, efficient entry point for healthcare innovators developing medical devices, drugs and diagnostics.

2Clinical Trial Design Services
CategoryClinical Trial Design
Description

Comprehensive clinical trial design services including systematic literature review, key opinion leader sourcing, trial design incorporating pilot studies and biostatistics input, and reimbursement/market access considerations. Designed for medical device, drug and diagnostic innovators who need help designing an effective clinical trial.

3Clinical Trial Management Services
CategoryClinical Trial Management
Description

Full-service clinical trial management including planning, site selection, regulatory/ethics coordination, database design, study monitoring, pharmacovigilance, data query resolution, and study close-out. Delivered using a risk-based approach to optimise recruitment, data collection and site performance, with proactive project management.

4Clinical Evaluation Report (CER) Services
CategoryClinical Evaluation Reporting
Description

Post-clinical trial data analysis, management, and clinical evaluation report preparation for regulatory submissions. Supports medical device companies seeking regulatory approval and market uptake by translating clinical data into CERs aligned with applicable regulations.

5Medical Writing Services
CategoryMedical Writing
Description

Professional medical writing services for clinical trial documentation, including protocols, informed consents, patient information leaflets, and study reports. Available as a standalone service for sponsors needing high-quality regulatory and clinical writing support.

6Data Monitoring Committee (DMC) Services
CategoryClinical Trial Oversight
Description

Data Monitoring Committee support services providing independent safety oversight during clinical trials. Bookable as a standalone service for sponsors requiring independent safety review infrastructure.

7Patient and Public Involvement (PPI) Services
CategoryPatient Engagement
Description

Patient and public involvement services to identify recruitment issues and concerns, and to ensure trials are designed for participant retention. Bookable as a standalone service for sponsors and research consortia seeking patient-centred trial design.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierPreferred ProviderTypeTechnology or Integration
Description

Share CRF is listed as the preferred provider for database design and implementation. The use of Share CRF ensures seamless database design and implementation, with effective data management support including training, query management, reports and data exports.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Parexel is a major global CRO providing Phase I–IV clinical development, regulatory, and market access services to biopharma and medical device sponsors. It is a direct competitor for full-service trial work, with broader geographic reach and deeper therapeutic specialization than Afortiori.

TypeDirect peer
Description

Veramed is a UK-based CRO providing biostatistics, statistical programming, data management, and clinical trial services to pharma and medical device clients. It is comparable to Afortiori in geographic focus and mid-market CRO orientation, with overlapping biostatistics and trial management capabilities.

3Catapult Life Sciences
TypeDirect peer
Description

Catapult Life Sciences is a UK-based CRO providing clinical trial management, regulatory affairs, and pharmacovigilance services to pharma and medtech clients. It is a closely comparable peer in size, geography, and full-service orientation to mid-sized European sponsors.

TypeDirect peer
Description

MAC Clinical Research is a UK-headquartered CRO operating early-phase clinical trials, including Phase I units, with biostatistics and data management capabilities. It is comparable to Afortiori in UK origin and clinical trial focus, though more concentrated in early-phase healthy volunteer studies.

TypeBroad incumbent
Description

IQVIA is the largest global full-service CRO and clinical research services provider, offering trial design, management, real-world evidence, and technology platforms. It competes with Afortiori in the full-service clinical trial space, but at vastly greater scale and with proprietary technology.

TypeDirect peer
Description

Richmond Pharmacology is a UK-based CRO specializing in early-phase clinical trials, including first-in-human and clinical pharmacology studies. It is a relevant peer for Afortiori's early-phase drug work, given overlapping UK location and trial execution focus.

TypeDirect peer
Description

Cromos Pharma is a mid-sized full-service CRO with operations in Eastern Europe and the US, serving biopharma and medical device sponsors across multiple therapeutic areas. It competes for similar mid-market full-service work and offers comparable Phase II–IV capabilities.

TypeEmerging player
Description

Lindus Health is an emerging tech-enabled CRO focused on running clinical trials for digital health, medical device, and consumer health sponsors. It overlaps with Afortiori's medical device and wearable technology segments but competes with a more software-driven, decentralized trial model.

TypeBroad incumbent
Description

ICON is a top-tier global CRO offering full-service clinical research, laboratory, and consulting services across all therapeutic areas and phases. It overlaps directly with Afortiori's full-service clinical trial offering but serves much larger, late-stage programs globally.

TypeDirect peer
Description

Clinipace is a mid-sized full-service CRO focused on small to mid-sized biopharma and medical device sponsors, with therapeutic expertise across oncology, rare disease, and other areas. It mirrors Afortiori's target customer profile and full-service model but operates at greater scale in the US.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Afortiori Development

Clinical Research Services (CRO)aftdev.com

Afortiori Development is a founder-led UK-based full-service CRO providing clinical trial strategy, design, and management services for biopharmaceutical, medical device, diagnostics, and wearable technology innovators across the UK, Ireland, and the US.

What Afortiori Development does

Afortiori Development Limited is a privately-held, founder-led Contract Research Organisation (CRO) headquartered in Nottingham, England, with additional registered offices in Galway, Ireland and the United States. The company provides full-service clinical trial design, planning and management for healthcare product developers, with current emphasis on medical devices (Classes I–III), drugs, diagnostics, and wearable technology products. Its offering is organised around three integrated phases — Clinical Strategy Planning (a half-day validation workshop), Clinical Trial Design, and Clinical Trial Management — supported by specialised modules for Medical Writing, Data Monitoring Committee services, Patient and Public Involvement, and Clinical Evaluation Report (CER) preparation. Delivery is professional services-based, project-priced and not publicly disclosed, with engagements sourced through direct enterprise sales, referrals, and a partner channel for CROs without UK/Ireland representation.

Operationally, Afortiori is built on a specialist team of medical writers, data managers, biostatisticians, regulatory specialists, medical monitors, clinical project managers, clinical research associates, and reimbursement specialists, anchored by co-founders Dr Nicola Wall and Elizabeth Ralph. The firm differentiates on a risk-based clinical trial management approach, ISO 9001:2015 certification, and a global trusted-partner network of clinicians, biostatisticians, regulatory and reimbursement experts. Customer evidence to date is limited and project-based, including a Japanese Class I medical device company entering the European market, a leading Irish university (multi-site Phase 2 SARS-CoV-2 study), and a small cardiovascular biotech (Phase I trials). The company is independently owned by its two founders with no disclosed external investment, parent company, or restructuring events.

Afortiori Development firmographics

Firmographics
Name
Afortiori Development
Legal name
Afortiori Development Limited
Website
https://aftdev.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
Afortiori Development is a founder-led UK-based full-service CRO providing clinical trial strategy, design, and management services for biopharmaceutical, medical device, diagnostics, and wearable technology innovators across the UK, Ireland, and the US.
Ownership category
akta.pro rank

Afortiori Development industry classification

Industry
Product category
Clinical Research Services (CRO)
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Other Scientific and Technical Consulting Services (541690)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAOAB
Data Management, Biostatistics & Statistical Programming FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAOAC
Medical Writing & Clinical Documentation FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Clinical trial services
  • Contract research organization
  • Medical device clinical trials
  • Clinical strategy planning
  • Clinical trial management

Where Afortiori Development is headquartered

Location

Headquarters

HQ city
Galway
HQ country
Ireland
HQ region
Europe

Offices2 records

Markets served

Afortiori Development business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Trial CRO Services: Full-service clinical research organisation providing end-to-end clinical trial services including strategy planning, trial design, and trial management. Revenue generated through professional services contracts for medical devices, drugs, and diagnostics development.
  2. Clinical Strategy Planning Workshops: Half-day focused strategy workshops offering affordable, efficient approach to help clients develop clinical trial strategies. Workshop provides understanding of optimum clinical trial strategy, regulatory strategy insights, funding requirements, and access to global network of expertise.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Afortiori Development product offering

Product offering

Core offering

Afortiori Development is a full-service Contract Research Organization (CRO) that designs, plans, and manages clinical trials and post-market clinical follow-up studies for medical devices, drugs, and diagnostics. The company offers a three-phase integrated service — Clinical Strategy Planning Workshops, Clinical Trial Design Services, and Clinical Trial Management Services — supplemented by Medical Writing, Data Monitoring Committee (DMC), Patient and Public Involvement (PPI), and Clinical Evaluation Report (CER) services. Its core offering is delivered as bespoke professional services engagements tailored to healthcare innovators across the UK, Ireland, the United States, and globally.

Product overview

Afortiori Development is a full-service Contract Research Organization (CRO) offering a comprehensive suite of clinical trial services. The core offering consists of three integrated phases: Clinical Strategy Planning Workshop (initial strategy and planning), Clinical Trial Design Services (protocol development and trial architecture), and Clinical Trial Management Services (execution and oversight). These are supplemented by specialized service modules including Medical Writing, DMC Services, PPI Services, and Clinical Evaluation Report (CER) Services. The integrated approach spans from initial concept through post-market clinical follow-up studies essential for regulatory approval and market uptake of healthcare products.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Strategy Planning Workshop A focused half-day strategy workshop led by founders Dr Nicola Wall and Elizabeth Ralph with clinical trial specialists, clinicians, biostatisticians, and regulatory/reimbursement experts. Delivers an understanding of the optimum clinical trial strategy, regulatory and commercial considerations, funding requirements, and access to a global network of expertise. Designed as an affordable, efficient entry point for healthcare innovators developing medical devices, drugs and diagnostics.
  • Clinical Trial Design Services Comprehensive clinical trial design services including systematic literature review, key opinion leader sourcing, trial design incorporating pilot studies and biostatistics input, and reimbursement/market access considerations. Designed for medical device, drug and diagnostic innovators who need help designing an effective clinical trial.
  • Clinical Trial Management Services Full-service clinical trial management including planning, site selection, regulatory/ethics coordination, database design, study monitoring, pharmacovigilance, data query resolution, and study close-out. Delivered using a risk-based approach to optimise recruitment, data collection and site performance, with proactive project management.
  • Clinical Evaluation Report (CER) Services Post-clinical trial data analysis, management, and clinical evaluation report preparation for regulatory submissions. Supports medical device companies seeking regulatory approval and market uptake by translating clinical data into CERs aligned with applicable regulations.
  • Medical Writing Services Professional medical writing services for clinical trial documentation, including protocols, informed consents, patient information leaflets, and study reports. Available as a standalone service for sponsors needing high-quality regulatory and clinical writing support.
  • Data Monitoring Committee (DMC) Services Data Monitoring Committee support services providing independent safety oversight during clinical trials. Bookable as a standalone service for sponsors requiring independent safety review infrastructure.
  • Patient and Public Involvement (PPI) Services Patient and public involvement services to identify recruitment issues and concerns, and to ensure trials are designed for participant retention. Bookable as a standalone service for sponsors and research consortia seeking patient-centred trial design.

Quantifiable outcome

  • Cost-effective clinical trial design with best chance of success
  • +1 more outcomes

Companies that use Afortiori Development

Customer profile

Named customers3 records

Segments8 records

Ideal customer profiles6 records

Afortiori Development technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Afortiori Development partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Share CRFpreferred providerTechnology or IntegrationShare CRF is listed as the preferred provider for database design and implementation. The use of Share CRF ensures seamless database design and implementation, with effective data management support including training, query management, reports and data exports.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Afortiori Development competitors and assessment

Company assessment

Broad incumbents

  • Parexel: Parexel is a major global CRO providing Phase I–IV clinical development, regulatory, and market access services to biopharma and medical device sponsors. It is a direct competitor for full-service trial work, with broader geographic reach and deeper therapeutic specialization than Afortiori.
  • IQVIA: IQVIA is the largest global full-service CRO and clinical research services provider, offering trial design, management, real-world evidence, and technology platforms. It competes with Afortiori in the full-service clinical trial space, but at vastly greater scale and with proprietary technology.
  • ICON plc: ICON is a top-tier global CRO offering full-service clinical research, laboratory, and consulting services across all therapeutic areas and phases. It overlaps directly with Afortiori's full-service clinical trial offering but serves much larger, late-stage programs globally.

Direct peers

  • Veramed: Veramed is a UK-based CRO providing biostatistics, statistical programming, data management, and clinical trial services to pharma and medical device clients. It is comparable to Afortiori in geographic focus and mid-market CRO orientation, with overlapping biostatistics and trial management capabilities.
  • Catapult Life Sciences: Catapult Life Sciences is a UK-based CRO providing clinical trial management, regulatory affairs, and pharmacovigilance services to pharma and medtech clients. It is a closely comparable peer in size, geography, and full-service orientation to mid-sized European sponsors.
  • MAC Clinical Research: MAC Clinical Research is a UK-headquartered CRO operating early-phase clinical trials, including Phase I units, with biostatistics and data management capabilities. It is comparable to Afortiori in UK origin and clinical trial focus, though more concentrated in early-phase healthy volunteer studies.
  • Richmond Pharmacology: Richmond Pharmacology is a UK-based CRO specializing in early-phase clinical trials, including first-in-human and clinical pharmacology studies. It is a relevant peer for Afortiori's early-phase drug work, given overlapping UK location and trial execution focus.
  • Cromos Pharma: Cromos Pharma is a mid-sized full-service CRO with operations in Eastern Europe and the US, serving biopharma and medical device sponsors across multiple therapeutic areas. It competes for similar mid-market full-service work and offers comparable Phase II–IV capabilities.
  • Clinipace Worldwide: Clinipace is a mid-sized full-service CRO focused on small to mid-sized biopharma and medical device sponsors, with therapeutic expertise across oncology, rare disease, and other areas. It mirrors Afortiori's target customer profile and full-service model but operates at greater scale in the US.

Emerging players

  • Lindus Health: Lindus Health is an emerging tech-enabled CRO focused on running clinical trials for digital health, medical device, and consumer health sponsors. It overlaps with Afortiori's medical device and wearable technology segments but competes with a more software-driven, decentralized trial model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Afortiori Development social profiles

Digital presence

Afortiori Development compliance and trust

Trust signal

Compliance1 record

Afortiori Development financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Afortiori Development leadership team

Management profile

Number of profiles

Profiles2 records

Afortiori Development funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Afortiori Development M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Afortiori Development

What does Afortiori Development do?

Afortiori Development is a full-service Contract Research Organization (CRO) that designs, plans, and manages clinical trials and post-market clinical follow-up studies for medical devices, drugs, and diagnostics. The company offers a three-phase integrated service — Clinical Strategy Planning Workshops, Clinical Trial Design Services, and Clinical Trial Management Services — supplemented by Medical Writing, Data Monitoring Committee (DMC), Patient and Public Involvement (PPI), and Clinical Evaluation Report (CER) services. Its core offering is delivered as bespoke professional services engagements tailored to healthcare innovators across the UK, Ireland, the United States, and globally.

Is Afortiori Development a public or private company?

Afortiori Development is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Afortiori Development founded?

Afortiori Development was founded in 2016. It employs 1 to 10 people.

Where is Afortiori Development based?

Afortiori Development is headquartered in Galway, Ireland, in the Europe region.

How does Afortiori Development make money?

Two revenue lines are on record. Clinical Trial CRO Services are the primary driver. The others are clinical Strategy Planning Workshops.

Who are Afortiori Development's main competitors?

Broad incumbents on record are Parexel, IQVIA and ICON plc. Direct peers are Veramed, Catapult Life Sciences, MAC Clinical Research, Richmond Pharmacology, Cromos Pharma and Clinipace Worldwide. Lindus Health is listed as an emerging player.

Does Afortiori Development have an API?

No public API is recorded for Afortiori Development.

What industry is Afortiori Development in?

Afortiori Development's product category is Clinical Research Services (CRO). Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales